Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

JW Pharmaceutical signs global out-licensing agreement for their novel atopic dermatitis drug candidate, JW1601, with LEO Pharma, a global leader in medical dermatology

Monday, August 27, 2018

JW Pharmaceutical and LEO Pharma AS announced today that they have signed a global licensing agreement for JWPs novel atopic dermatitis drug candidate JW under which LEO Pharma a global leader in medical dermatology will gain the exclusive rights to...

Adverum Biotechnologies Receives Orphan Drug Designation for ADVM-053, a Novel Gene Therapy Candidate for the Treatment of Hereditary Angioedema

Monday, August 27, 2018

Adverum Biotechnologies Inc a clinicalstage gene therapy company targeting unmet medical needs in serious rare and ocular diseases today announced that the United States US Food and Drug Administration FDA has granted Orphan Drug Designation ODD to A...

PTC Therapeutics Successfully Completes Acquisition of Agilis Biotherapeutics

Friday, August 24, 2018

PTC Therapeutics Inc today announced that it has successfully completed the acquisition of Agilis Biotherapeutics Inc a private biotechnology company focused on the advancement of innovative gene therapy programs for rare genetic disorders that affec...

Telix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer

Friday, August 24, 2018

Telix Pharmaceuticals Limited has today announced a research collaboration with the University of Melbourne to investigate the use of targeted radiopharmaceuticals or molecularlytargeted radiation MTR to provide improved treatments for colorectal can...

Onconova Therapeutics Announces Plan for Expanding Rigosertib Clinical Trials for Patients with Myelodysplastic Syndromes (MDS) to South America with Pint Pharma

Thursday, August 23, 2018

Onconova Therapeutics Inc a Phase stage biopharmaceutical company focused on discovering and developing novel products to treat cancer with a primary focus on myelodysplastic syndromes MDS today announced that its commercial partner Pint Pharma GmbH...

Revive Therapeutics Applies To FDA For Orphan Drug Designation of Cannabidiol For Treatment Of Liver Transplantation

Thursday, August 23, 2018

Revive Therapeutics Ltd a specialty medical cannabis company today announced that it has submitted an application to the US Food and Drug Administration FDA seeking orphan drug designation of cannabidiol CBD for the treatment of hepatic ischemia and...

Enigma Biomedical Group and Invicro Sign a Collaboration Agreement

Tuesday, August 21, 2018

Enigma Biomedical Group EBG today announced a collaboration agreement with Invicro a Konica Minolta Company and a leading provider of imaging services and software for research and drug development to work together on multiple projects initially focu...

Bertilimumab Granted Orphan Drug Designation for the Treatment of Bullous Pemphigoid

Tuesday, August 21, 2018

Immune Pharmaceuticals Inc a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases today announced that the US Food and Drug Administration FDA has granted Orphan Drug Designation ODD...

And Platinum Pharmaceuticals and Columbotech Global Strategic Cooperation on PD-L1 Antibody A167

Monday, August 20, 2018

With Plasma BioMed and Sichuan Kelun Botai Biomedical Co Ltd focusing on innovative drug development Columbotech announced the global strategic cooperation and Platinum Pharmaceuticals will receive the exclusive development production and commercial...

Tolero Pharmaceuticals Announces Clinical Research Collaboration with AbbVie for Acute Myeloid Leukemia Trial

Saturday, August 18, 2018

Tolero Pharmaceuticals Inc a clinicalstage biopharmaceutical company focused on developing treatments for hematologic and oncologic diseases has entered into a clinical research collaboration with AbbVie a researchbased global biopharmaceutical compa...